Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
Explore this paper's citation graph
Summary
Simvastatin plus niacin provides marked clinical and angiographically measurable benefits in patients with coronary disease and low HDL levels, and the use of antioxidant vitamins in this setting must be questioned.
- Type
- article
- Published
- 2001-11-29
- Cited by
- 1,851
- References
- 35
- Access
- Open access
- OpenAlex
- https://openalex.org/W2046991199
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23922027
Keywords
Niacin, Simvastatin, Medicine, Internal medicine, Placebo
References
- The Münster Heart Study (PROCAM). Results of follow-up at 8 years.
- Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
- A maximum confidence approach for measuring progression and regression of coronary artery disease in clinical trials.
- Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.
- Antioxidant vitamin supplementation and lipid peroxidation in smokers.
- Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association.
- Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.
- Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease.
- High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.
- Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study.
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
- Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report.
- Quantitative computer techniques for analyzing coronary arteriograms.
- Plasma Lipoproteins and Progression of Coronary Artery Disease Evaluated by Angiography and Clinical Events
- Hepatic lipase: new insights from genetic and metabolic studies.
- Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease
- Quantitative determination of human apolipoprotein C-III by electroimmunoassay.
- Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
- Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
- Quantitative Ultrastructural Analysis of Perifibrous Lipid and Its Association with Elastin in Nonatherosclerotic Human Aorta
Cited by
- Pl13 Nuevas aportaciones sobre efectos del espino blanco (Crataegus sp.) en patología cardiovascular
- Overcoming ‘Ageism’ Bias in the Treatment of Hypercholesterolaemia
- Six-Year Effect of Combined Vitamin C and E Supplementation on Atherosclerotic Progression: The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study
- Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes.
- Raising an isolated low HDL-C level: why, how, and when?
- Oxidative stress in childhood--in health and disease states.
- Microencapsulated Genetically Engineered Lactobacillus plantarum 80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering Cholesterol
- Atherosclerotic Cardiovascular Disease Risk in the HAART-Treated HIV-1 Population
- Morphoproteomics: exposing protein circuitries in tumors to identify potential therapeutic targets in cancer patients
- Essential nutrients: food or supplements? Where should the emphasis be?
- High-density lipoprotein cholesterol therapies: the next frontier in lipid management.
- Vitamin E increases the risk of developing heart failure after myocardial infarction: results from the GISSI-Prevenzione trial
- Fibrates: What Have We Learned in the Past 40 Years?
- American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.
- Vitamin E dietary supplementation significantly affects multiple risk factors for cardiovascular disease in baboons.
- Comprehensive management of cardiometabolic risk factors.
- Strategies to reverse atherosclerosis: An imaging perspective
- Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study.
- Vitamin E and all-cause mortality: A meta-analysis
- Revisiting niacin: reviewing the evidence.
Related papers
- Management of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin
- Niacin Extended-Release/Simvastatin
- Effect of simvastatin in patients with type I (insulin-dependent) diabetes mellitus and hypercholesterolemia.
- Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy Subjects
- Niacin improves adiponectin secretion, glucose tolerance and insulin sensitivity in diet-induced obese rats
- Sex-specific effect of dietary cholesterol on plasma insulin and lipids of control and diabetic rats
- Fixed-dose combination of extended-release niacin plus simvastatin for lipid disorders
- EFFECTS OF INHIBITION OF CHOLESTEROL SYNTHESIS BY SIMVASTATIN ON THE PRODUCTION OF ADRENOCORTICAL STEROID HORMONES AND ACTH